Skip to main content
OpenTrials

Clinical trial condition

Gastrointestinal Neoplasms

Explore clinical trials studying Gastrointestinal Neoplasms. Study availability and eligibility vary by location and protocol.

9,197 public trials 2,038 recruiting studies
Refine in advanced search Browse all conditions

Gastrointestinal Neoplasms trial results

Active, not recruiting

Therapeutic Cancer Vaccine (AST-301, pNGVL3-hICD) in Gastric Cancer

NCT05771584

Conditions
Digestive System Diseases, Digestive System Neoplasms, Gastric Cancer, +6 more
Locations
  • Kaohsiung Medical University Chung-Ho Memorial Hospital Kaohsiung City, Taiwan
  • China Medical University Hospital Taichung, Taiwan
  • Taichung Veterans General Hospital Taichung, Taiwan
  • Chi Mei Medical Center Tainan, Taiwan
View Trial Details
Active, not recruiting

Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 Mutations

NCT04521686

Conditions
Adenocarcinoma, Any Solid Tumor, Astrocytoma, +49 more
Locations
  • Mayo Clinic of Scottsdale Phoenix, Arizona, United States
  • The University of Arizona Cancer Center Tucson, Arizona, United States
  • USC Norris Cancer Hospital Los Angeles, California, United States
  • Mayo Clinic in Florida Jacksonville, Florida, United States
View all 33 locations
View Trial Details
Active, not recruiting

A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid Tumors

NCT06607185

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced Solid Tumor, +53 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Mayo Clinic Phoenix, Arizona, United States
  • City of Hope Duarte, California, United States
  • University of California, Los Angeles (UCLA) Santa Monica, California, United States
View all 45 locations
View Trial Details
Active, not recruiting

Physically Active During Cancer Treatment (FAKT)

NCT03885817

Conditions
Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +15 more
Locations
  • Ålesund sjukehus Ålesund, Norway
  • Sørlandet sykehus, Kristiansand Kristiansand, Norway
  • Levanger sykehus Levanger, Norway
  • Ullevål Oslo, Norway
View Trial Details
Active, not recruiting

Pembrolizumab in Treating Younger Patients With Recurrent, Progressive, or Refractory High-Grade Gliomas, Diffuse Intrinsic Pontine Gliomas, Hypermutated Brain Tumors, Ependymoma or Medulloblastoma

NCT02359565

Conditions
Brain Diseases, Brain Neoplasms, Brain Stem Neoplasms, +46 more
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Lucile Packard Children's Hospital Stanford University Palo Alto, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
View Trial Details
Active, not recruiting

Study of XL092 + Atezolizumab vs Regorafenib in Participants With Metastatic Colorectal Cancer

NCT05425940

Conditions
Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +9 more
Locations
  • Exelixis Clinical Site #65 Jonesboro, Alabama, United States
  • Exelixis Clinical Site #30 Phoenix, Arizona, United States
  • Exelixis Clinical Site #70 Tucson, Arizona, United States
  • Exelixis Clinical Site #9 Duarte, California, United States
View all 133 locations
View Trial Details

Related conditions